Top

BMC Pregnancy and Childbirth

Published in:

Open Access 01-12-2022 | Vaccination | Research

Safety of SARS-CoV-2 vaccination during pregnancy- obstetric outcomes from a large cohort study

Authors: Aharon Dick, Joshua I Rosenbloom, Einat Gutman-Ido, Naama Lessans, Adva Cahen-Peretz, Henry H Chill

Published in: BMC Pregnancy and Childbirth | Issue 1/2022

Abstract

Background

COVID-19 during pregnancy is associated with adverse outcomes for mother and fetus. SARS-CoV-2 vaccination has significantly reduced the risk of symptomatic disease. Several small studies have reported the safety of SARS-CoV-2 vaccination during pregnancy, with no adverse effect on obstetric outcomes.

Objective

To examine the association between SARS-CoV-2 vaccination during pregnancy and maternal and neonatal outcomes in a large cohort study. Furthermore, to evaluate if timing of vaccination during pregnancy is related to adverse outcomes.

Methods

A retrospective cohort study of women who delivered between December 2020 and July 2021 at a large tertiary medical center. Excluded were women with multiple pregnancy, vaccination prior to pregnancy, COVID-19 infection during or before pregnancy, or unknown timing of vaccination. Primary outcomes were the incidence of preterm labor and of small for gestational age. Secondary outcomes were other maternal and neonatal complications. A secondary analysis investigating the association between time of vaccination and outcomes was also performed. Multivariable logistic regression models were used to adjust for potential confounders.

Results

There were 5618 women who met the inclusion criteria: 2,305 (41%) women were vaccinated and 3,313 (59%) were unvaccinated. There were no differences between vaccinated and non-vaccinated patients with respect to primary outcomes. The rate of preterm birth was 5.5% in the vaccinated group compared to 6.2% in the unvaccinated group (p = 0.31). Likewise, the rates of small for gestational age were comparable between the two groups (6.2% vs. 7.0% respectively, p = 0.2).

In a secondary analysis focusing on time of vaccination and its relationship with outcomes, patients vaccinated in the second trimester (n = 964) and in the third trimester (n = 1329) were independently compared to their unvaccinated counterparts. Women who were vaccinated in the second trimester were more likely to have a preterm birth (8.1% vs. 6.2%, p < 0.001). This association persisted after adjusting for potential confounders (adjusted odds ratio 1.49, 95%CI 1.11, 2.01).

Conclusions

SARS-CoV-2 vaccine appears to be safe during pregnancy with no increase in incidence of preterm labor and small for gestational age compared to unvaccinated women. However, in women vaccinated during the second trimester there may be an increase in the rate of preterm birth.

Data from WHO website: https://covid19.who.int/. Accessed 1 Oct 2021.

Pham A, Aronoff DM, Thompson JL. Maternal COVID-19, vaccination safety in pregnancy, and evidence of protective immunity. J Allergy Clin Immunol. 2021;148(3). https://doi.org/10.1016/j.jaci.2021.07.013

Oltean I, Tran J, Lawrence S, et al. Impact of SARS-CoV-2 on the clinical outcomes and placental pathology of pregnant women and their infants: A systematic review. Heliyon. 2021;7(3). https://doi.org/10.1016/j.heliyon.2021.e06393

Metz TD, Clifton RG, Hughes BL, et al. Disease Severity and Perinatal Outcomes of Pregnant Patients With Coronavirus Disease 2019 (COVID-19). Obstet Gynecol. 2021;137(4):571–580. https://doi.org/10.1097/AOG.0000000000004339CrossRefPubMedPubMedCentral

Villar J, Ariff S, Gunier RB, et al. Maternal and Neonatal Morbidity and Mortality among Pregnant Women with and without COVID-19 Infection: The INTERCOVID Multinational Cohort Study. JAMA Pediatr. 2021;175(8):817–826. https://doi.org/10.1001/jamapediatrics.2021.1050CrossRefPubMed

Sahin D, Tanacan A, Erol SA, et al. Management of pregnant women with COVID-19: A tertiary pandemic center experience on 1416 cases [published online ahead of print, 2021 Oct 29]. J Med Virol. 2021; https://doi.org/10.1002/jmv.27423.

Dagan N, Barda N, Kepten E, et al. BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting. N Engl J Med. 2021;384(15). https://doi.org/10.1056/nejmoa2101765

The Center of Disease Control. Accessed April 18, 2021. https://www.cdc.gov/coronavirus/2019-ncov/vaccines/recommendations/pregnancy.html

The American College of Obstetrics and Gynecology. Accessed April 18, 2021. https://www.acog.org/clinical/clinical-guidance/practice-advisory/articles/2020/12/vaccinating-pregnant-and-lactating-patients-against-covid-19#:~:text=ACOG recommends that COVID-19,on ACIP-recommended priority groups

10.

Wainstock T, Yoles I, Sergienko R, Sheiner E. Prenatal maternal COVID-19 vaccination and pregnancy outcomes. Vaccine. 2021;39(41):6037–6040. https://doi.org/10.1016/j.vaccine.2021.09.012CrossRefPubMedPubMedCentral

11.

Blakeway H, Prasad S, Kalafat E, et al. COVID-19 vaccination during pregnancy: coverage and safety. Am J Obstet Gynecol. Published online 2021:1–14. https://doi.org/10.1016/j.ajog.2021.08.007

12.

Theiler RN, Wick M, Mehta R, Weaver AL, Virk A, Swift M. Pregnancy and birth outcomes after SARS-CoV-2 vaccination in pregnancy. Am J Obstet Gynecol MFM. 2021;3(6):100467. https://doi.org/10.1016/j.ajogmf.2021.100467CrossRefPubMedPubMedCentral

13.

Shimabukuro TT, Kim SY, Myers TR, et al. Preliminary Findings of mRNA Covid-19 Vaccine Safety in Pregnant Persons. N Engl J Med. 2021;384(24). https://doi.org/10.1056/nejmoa2104983

14.

Munoz FM. Can We Protect Pregnant Women and Young Infants from COVID-19 through Maternal Immunization? JAMA Pediatr. 2021;175(6). https://doi.org/10.1001/jamapediatrics.2021.0043

15.

Flannery DD, Gouma S, Dhudasia MB, et al. Assessment of Maternal and Neonatal Cord Blood SARS-CoV-2 Antibodies and Placental Transfer Ratios. JAMA Pediatr. 2021;175(6). https://doi.org/10.1001/jamapediatrics.2021.0038

16.

Dollberg S, Haklai Z, Mimouni FB, Gorfein I, Gordon ES. Birthweight standards in the live-born population in Israel. Isr Med Assoc J. 2005;7(5).

17.

ACOG Practice Bulletin No. 190: Gestational Diabetes Mellitus. Obstet Gynecol. 2018;131(2). https://doi.org/10.1097/AOG.0000000000002501

18.

Rottenstreich M, Sela HY, Rotem R, Kadish E, Wiener-Well Y, Grisaru-Granovsky S. Covid-19 vaccination during the third trimester of pregnancy: rate of vaccination and maternal and neonatal outcomes, a multicentre retrospective cohort study. BJOG. 2022;129(2):248–255.CrossRef

Title: Safety of SARS-CoV-2 vaccination during pregnancy- obstetric outcomes from a large cohort study
Authors: Aharon Dick
Joshua I Rosenbloom
Einat Gutman-Ido
Naama Lessans
Adva Cahen-Peretz
Henry H Chill
Publication date: 01-12-2022
Publisher: BioMed Central
Keywords: Vaccination
SARS-CoV-2
Premature Birth
Published in: BMC Pregnancy and Childbirth / Issue 1/2022
Electronic ISSN: 1471-2393
DOI: https://doi.org/10.1186/s12884-022-04505-5

At a glance: The STEP trials

Springer Medicine

Safety of SARS-CoV-2 vaccination during pregnancy- obstetric outcomes from a large cohort study

Abstract

Background

Objective

Methods

Results

Conclusions

At a glance: The STEP trials

Springer Medicine

Abstract

Background

Objective

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 1/2022

Acute endometriosis-related sigmoid perforation in pregnancy- case report

Association of preconception dysmenorrhea with obstetric complications: the Japan Environment and Children’s Study

Understanding context in the implementation of emergency obstetric and neonatal care in health facilities in Osun State, Nigeria- a mixed-methods study

Pregnancy maternal fetal outcomes among pregnancies complicated with atrioventricular block

Quality of surgical management of placenta accreta spectrum in a tertiary center in Sri Lanka: baseline study for quality improvement project: problems and solutions

Adverse obstetric and neonatal outcomes of adolescent pregnancies in Africa: a scoping review